Michael C Schneider

US Patent:

7109689, Sep 19, 2006

Filed:

Oct 17, 2003

Appl. No.:

10/688498

Inventors:

Michael Edwin Schneider - Austin TX, US

Assignee:

Intersil Americas Inc. - Milpitas CA

International Classification:

G05F 1/59

US Classification:

323272, 323284

Abstract:

A regulator supplies a regulated voltage to an electronic component with a plurality of phases with varying response rates. The regulator includes an output node that provides a regulated supply voltage, a first main-phase drive circuit that provides a first main load current to the output node and that has an on time and an off time, and a first transient-phase drive circuit that has a first transient load current to the output node that has an on time and an off time that are respectively less than the on and off times of the first main-phase drive circuit.

US Patent:

20010008026, Jul 12, 2001

Filed:

Jun 25, 1998

Appl. No.:

09/104654

Inventors:

MICHAEL D. SCHNEIDER - HOUSTON TX, US
PAUL OVERBEEK - HOUSTON TX, US
PETER FRENKEL - HOUSTON TX, US

International Classification:

A01K067/027

US Classification:

800/008000, 800/009000, 800/014000, 800/018000, 800/003000, 800/021000, 800/022000, 800/025000, 435/455000, 435/462000, 435/463000, 435/465000, 435/325000

Abstract:

The present invention relates to methods and compositions for tissue-restricted gene recombination. In particular, the present invention provides methods and compositions for tissue-restricted gene recombination in post-mitotic cells. The present invention further provides methods for gene recombination in post-mitotic cells comprising the delivery of a Cre recombinase to the target tissue to facilitate recombination in a desired target nucleic acid.

US Patent:

20040082613, Apr 29, 2004

Filed:

Jun 27, 2003

Appl. No.:

10/609073

Inventors:

Michael Schneider - Houston TX, US
Motoaki Sano - Houston TX, US

International Classification:

A61K031/452
A61K031/401

US Classification:

514/320000, 514/423000

Abstract:

The present invention relates generally to the field of cardiology. More particularly, the present invention relates to methods of using inhibitors of cyclin dependent kinase 9 (Cdk9) to treat cardiovascular disease by blunting cardiac hypertrophy.

US Patent:

20040106647, Jun 3, 2004

Filed:

Sep 19, 2003

Appl. No.:

10/665336

Inventors:

Michael Schneider - Houston TX, US
Motoaki Sano - Houston TX, US

International Classification:

A61K031/452

US Classification:

514/320000

Abstract:

The present invention relates generally to the field of cardiology. More particularly, the present invention relates to methods of using inhibitors of cyclin dependent kinase 9 (Cdk9) to treat cardiovascular disease by blunting cardiac hypertrophy.

US Patent:

20040126879, Jul 1, 2004

Filed:

Aug 29, 2003

Appl. No.:

10/651548

Inventors:

Michael Schneider - Houston TX, US
Hidemasa Oh - Houston TX, US
Mark Entman - Houston TX, US

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

C12N005/08

US Classification:

435/372000, 435/366000, 424/093700

Abstract:

The present invention is drawn to compositions and methods of using the same to cardiovascular disease. The compositions of the present invention are cardiac stem cells that are c-kit/CD31/CD38 and express telomerase reverse transcriptase.

US Patent:

20040242461, Dec 2, 2004

Filed:

Apr 8, 2004

Appl. No.:

10/820583

Inventors:

Michael Schneider - Houston TX, US
Hidemasa Oh - Houston TX, US

International Classification:

A61K038/17

US Classification:

514/002000

Abstract:

The present invention embodies methods of modulating telomere repeat-binding factor-2 (TRF2) or cell cycle checkpoint kinase 2 (Chk2) to enhance the survival of a cell. More particularly, the modulators can be used to treat cardiovascular disease by improving the growth and survival of cardiomyocytes.

US Patent:

20050037241, Feb 17, 2005

Filed:

Aug 15, 2003

Appl. No.:

10/642091

Inventors:

Michael Schneider - Austin TX, US
Jinrong Qian - Plano TX, US
Sisan Shen - Plano TX, US
Brett Etter - Stewartsville NJ, US

Assignee:

Intersil Americas Inc. - Milpitas CA

International Classification:

H01M016/00

US Classification:

429009000

Abstract:

A multiple mode battery power supply contains first and second batteries, an external adapter port and a load port. The batteries are selectively connected to a node by way of associated power MOSFET switches. A power bus between the adapter port and the load port contains a MOSFET power switch. Finally a MOSFET power switch couples the node to the power bus. A controller selectively operates the power MOSFETS, to enable the load port to be powered by a selected one of any of an external adapter source of power, and one of the two batteries, while providing cross-conduction isolation among the external adapter source of power, and the batteries.

US Patent:

20050043260, Feb 24, 2005

Filed:

Apr 21, 2004

Appl. No.:

10/828669

Inventors:

Michael Schneider - Houston TX, US
Teruya Nakamura - Houston TX, US

Assignee:

BAYLOR COLLEGE OF MEDICINE - Houston TX

International Classification:

A61K048/00
C12N015/85

US Classification:

514044000, 435455000

Abstract:

The present invention relates to the fields of cell biology, molecular biology, and medicine. More specifically, the invention is directed to generating cardiomyocyte cells from non-cardiomyocyte cells by enhancing the activation of the Wnt/β-catenin signaling pathway. The cardiomyocyte cells that are generated in the present invention are then used as cardiac disease therapy.